Prevalence and risk of gingival overgrowth in patients treated with diltiazem or verapamil
- 1 March 2005
- journal article
- research article
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 32 (3), 294-298
- https://doi.org/10.1111/j.1600-051x.2005.00662.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugsEuropean Journal of Clinical Investigation, 2001
- Crevicular Fluid Interleukin‐1β, Tumor Necrosis Factor‐α, and Interleukin‐6 Levels in Renal Transplant Patients Receiving Cyclosporine AThe Journal of Periodontology, 1998
- Gingival Enlargement Induced by DrugsDrug Safety, 1996
- Evaluation of gingival and periodontal conditions following causal periodontal treatment in patients treated with nifedipine and diltiazem*Journal of Clinical Periodontology, 1996
- Clinical assessment of gingival hyperplasia in patients treated with nifedipineJournal of Clinical Periodontology, 1994
- On the mechanism of drug‐induced gingival hyperplasiaJournal of Oral Pathology & Medicine, 1991
- Gingival Hyperplasia Induced by Nifedipine.The Journal of Nihon University School of Dentistry, 1991
- Nitrendipine-induced gingival hyperplasia: First case reportOral Surgery, Oral Medicine, Oral Pathology, 1990
- Gingival overgrowth induced by diltiazem: A case reportOral Surgery, Oral Medicine, Oral Pathology, 1988
- Incidence of diphenylhydantoin gingival hyperplasiaOral Surgery, Oral Medicine, Oral Pathology, 1972